Hemagglutinin Glycoproteins, Influenza Virus/chemistry; Influenza A Virus, H3N2 Subtype/metabolism; Influenza Vaccines/chemistry; Chemical Phenomena; Cysteine/analysis; Cysteine/chemistry; Cystine/analysis; Cystine/chemistry; Drug Stability; Drug Storage; Excipients/chemistry; Hemagglutinin Glycoproteins, Influenza Virus/genetics; Hemagglutinin Glycoproteins, Influenza Virus/metabolism; Hemagglutinin Glycoproteins, Influenza Virus/pharmacology; Hydrodynamics; Immunodiffusion; Influenza A Virus, H3N2 Subtype/drug effects; Influenza A Virus, H3N2 Subtype/growth & development; Influenza A Virus, H3N2 Subtype/immunology; Influenza Vaccines/genetics; Influenza Vaccines/metabolism; Influenza Vaccines/pharmacology; Octoxynol/chemistry; Oxidation-Reduction; Peptide Mapping; Protein Stability; Protein Structure, Secondary; Recombinant Proteins/chemistry; Recombinant Proteins/genetics; Recombinant Proteins/metabolism; Recombinant Proteins/pharmacology; Spectroscopy, Fourier Transform Infrared; Temperature; Thioglycolates/chemistry

Flublok®; influenza; mass spectrometry; physicochemical; potency; protein formulation; recombinant hemagglutinin; single-radial immunodiffusion assay; stability; vaccines